Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.

Virus research - 1 Mar 2020

Goo Junghyun, Jeong Yuji, Park Young-Shin, Yang Eunji, Jung Dae-Im, Rho Semi, Park Uni, Sung Hyeyeong, Park Pil-Gu, Choi Jung-Ah, Seo Sang Hwan, Cho Nam Hyuck, Lee Hyeja, Lee Jae Myun, Kim Jae-Ouk, Song Manki

Abstract excerpt

Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary infection, with ∼35 % mortality. Spike glycoprotein (S) of MERS-CoV is a key target for vaccines and therapeutics because S mediates viral entry and membrane-fusion to host cells. Here, four different S subunit proteins, receptor-binding domain (RBD; 358-606 aa), S1 (1-751 aa), S2 (752-1296 aa), and SΔTM (1-1296 aa), were generated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross Protection

Share to Epitopes

Share to Middle East Respiratory Syndrome Coronavirus

Share to Neutralization Tests

Share to Protein Subunits

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 31945421
DOI: 10.1016/j.virusres.2020.197863
PMCID: PMC7114870

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.PMID 31945421Read ↗

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization EscapeSemantic proximity Read ↗

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinSemantic proximity Read ↗

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variantsSemantic proximity Read ↗

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variantsSemantic proximity Read ↗

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivoSemantic proximity Read ↗

Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane FusionSemantic proximity Read ↗

Stabilized coronavirus spike stem elicits a broadly protective antibodySemantic proximity Read ↗

Synthetic Monoclonal Antibody Designed for Novel SARS-nCoV-2 Spike-S1 Protein Antigenic Targeted Epitope of Receptor Binding Domain Inhibit to Prevent Viral EntrySemantic proximity Read ↗

Designed miniproteins potently inhibit and protect against MERS-CoVSemantic proximity Read ↗

Cross-Neutralizing Monoclonal Antibodies with Broad Activity Against Human and Bat-Derived SARS-Related CoronavirusesSemantic proximity Read ↗

Designed miniproteins potently inhibit and protect against MERS-CoVSemantic proximity Read ↗

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.